Deep Blue Biotech pioneers sustainable chemical production with genetically engineered cyanobacteria. By creating “net-positive” chemicals that absorb more CO2 than they emit, the startup aims to revolutionize the beauty industry and beyond while setting new trends in the fight against climate change.
In the ever-evolving landscape of sustainability, where the race against climate change is not just a marathon but a sprint, a small U.K. startup is daring to dream big.
Deep Blue Biotech, founded in the spring of 2023, is diving deep into the untapped potential of cyanobacteria, colloquially known as “pond scum,” to transform the chemical manufacturing industry.
This is not just a story about another startup; it’s a narrative about innovation at the intersection of nature and technology, where the humble cyanobacteria might just be the unsung hero in the battle for a greener planet.
The startup’s approach is refreshingly audacious.
While many companies are stuck in the quagmire of fossil fuel dependency, Deep Blue Biotech is leveraging the power of photosynthesis to create what they call “net-positive” chemicals.
These aren’t just any chemicals, but ones that absorb more CO2 than they emit during production.
Imagine, if you will, a world where the very process of creating essential products is also cleaning our air.
It’s not science fiction; it’s the future that Deep Blue Biotech is working to build.
At the heart of this innovation is a strain of cyanobacteria that, thanks to genetic engineering and computational modelling, has become a microscopic factory for sustainable chemicals.
This isn’t merely a rehash of past “green” efforts that were expensive and underwhelming.
As co-founder Manuel Rios candidly puts it, “The first generation of green chemicals, unfortunately, they just sucked.”
He speaks with the fervor of someone who’s seen the potential of what could be and is determined not to repeat the mistakes of the past.
Rios, with his background as a former VP of sustainable design at Unilever, is acutely aware of the pitfalls that have plagued the industry.
His vision for Deep Blue Biotech is not just about sustainability; it’s about functionality and cost-effectiveness.
This dual focus is what sets the startup apart.
By targeting high-value chemicals—those costing north of $2,000-$3,000 per kilo—Deep Blue Biotech is setting itself up not just for environmental impact, but for commercial success.
Their first foray into the market is hyaluronic acid, a staple in the beauty and cosmetics industry.
While it might seem trivial to focus on skincare when the planet is at stake, Rios argues that the beauty industry, with its massive consumer engagement, can be a powerful catalyst for change.
It’s a savvy move, targeting an industry that not only has the resources to support innovation but also the clout to shift public perception.
However, the journey is just beginning.
With an $800,000 pre-seed round led by Sustainable Ventures, Deep Blue Biotech is in the experimental phase, poised to scale up its technology.
The road ahead involves not just refining their production methods but also expanding their team and expertise.
Their modular photobioreactor system is a testament to their commitment to efficiency and scalability, allowing for rapid expansion without the costly infrastructure of traditional fermentation systems.
The competitive landscape is not without its formidable players.
Companies like Microphyt and Bondi Bio are exploring similar avenues, but Deep Blue Biotech is betting on its unique approach and insider industry knowledge to carve out its niche.
In a world where the urgency to decarbonize is palpable, Deep Blue Biotech offers a glimmer of hope.
They are not content with simply keeping pace with sustainability trends; they are setting them.
As the startup continues its journey, it serves as a reminder that sometimes, the smallest organisms can make the biggest impact.
And in the case of Deep Blue Biotech, perhaps the key to a sustainable future lies in the hands—or rather, the cells—of the unlikeliest of heroes: cyanobacteria.
